275 related articles for article (PubMed ID: 29361749)
41. Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?
Vannini A; Cheung K; Fusconi M; Stammen-Vogelzangs J; Drenth JP; Dall'Aglio AC; Bianchi FB; Bakker-Jonges LE; van Venrooij WJ; Pruijn GJ; Zendman AJ
Ann Rheum Dis; 2007 Apr; 66(4):511-6. PubMed ID: 16984940
[TBL] [Abstract][Full Text] [Related]
42. Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation.
Ytterberg AJ; Joshua V; Reynisdottir G; Tarasova NK; Rutishauser D; Ossipova E; Haj Hensvold A; Eklund A; Sköld CM; Grunewald J; Malmström V; Jakobsson PJ; Rönnelid J; Padyukov L; Zubarev RA; Klareskog L; Catrina AI
Ann Rheum Dis; 2015 Sep; 74(9):1772-7. PubMed ID: 24817415
[TBL] [Abstract][Full Text] [Related]
43. ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression.
van Beers JJ; Willemze A; Jansen JJ; Engbers GH; Salden M; Raats J; Drijfhout JW; van der Helm-van Mil AH; Toes RE; Pruijn GJ
Arthritis Res Ther; 2013 Oct; 15(5):R140. PubMed ID: 24286543
[TBL] [Abstract][Full Text] [Related]
44. The role of synthetic manufactured peptides containing common citrullinated epitopes in rheumatoid arthritis diagnosis.
Darawshe S; Watad A; Bragazzi NL; Gertel S; Amital H
Clin Immunol; 2019 Feb; 199():7-11. PubMed ID: 30543920
[TBL] [Abstract][Full Text] [Related]
45. Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis.
Johansson L; Pratesi F; Brink M; Ärlestig L; D'Amato C; Bartaloni D; Migliorini P; Rantapää-Dahlqvist S
Arthritis Res Ther; 2016 Jun; 18(1):127. PubMed ID: 27255888
[TBL] [Abstract][Full Text] [Related]
46. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.
Schellekens GA; de Jong BA; van den Hoogen FH; van de Putte LB; van Venrooij WJ
J Clin Invest; 1998 Jan; 101(1):273-81. PubMed ID: 9421490
[TBL] [Abstract][Full Text] [Related]
47. Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis.
Habets KL; Trouw LA; Levarht EW; Korporaal SJ; Habets PA; de Groot P; Huizinga TW; Toes RE
Arthritis Res Ther; 2015 Aug; 17(1):209. PubMed ID: 26268317
[TBL] [Abstract][Full Text] [Related]
48. Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies.
Pratesi F; Tommasi C; Anzilotti C; Puxeddu I; Sardano E; Di Colo G; Migliorini P
Clin Exp Immunol; 2011 Jun; 164(3):337-45. PubMed ID: 21413944
[TBL] [Abstract][Full Text] [Related]
49. Identification of new citrulline-specific autoantibodies, which bind to human arthritic cartilage, by mass spectrometric analysis of citrullinated type II collagen.
Haag S; Schneider N; Mason DE; Tuncel J; Andersson IE; Peters EC; Burkhardt H; Holmdahl R
Arthritis Rheumatol; 2014 Jun; 66(6):1440-9. PubMed ID: 24470447
[TBL] [Abstract][Full Text] [Related]
50. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
[TBL] [Abstract][Full Text] [Related]
51. Affinity Maturation of the Anti-Citrullinated Protein Antibody Paratope Drives Epitope Spreading and Polyreactivity in Rheumatoid Arthritis.
Kongpachith S; Lingampalli N; Ju CH; Blum LK; Lu DR; Elliott SE; Mao R; Robinson WH
Arthritis Rheumatol; 2019 Apr; 71(4):507-517. PubMed ID: 30811898
[TBL] [Abstract][Full Text] [Related]
52. Application of synthetic peptides for detection of anti-citrullinated peptide antibodies.
Trier NH; Holm BE; Slot O; Locht H; Lindegaard H; Svendsen A; Nielsen CT; Jacobsen S; Theander E; Houen G
Peptides; 2016 Feb; 76():87-95. PubMed ID: 26796582
[TBL] [Abstract][Full Text] [Related]
53. The antigen specificity of the rheumatoid arthritis-associated ACPA directed to citrullinated fibrin is very closely restricted.
Iobagiu C; Magyar A; Nogueira L; Cornillet M; Sebbag M; Arnaud J; Hudecz F; Serre G
J Autoimmun; 2011 Dec; 37(4):263-72. PubMed ID: 21872430
[TBL] [Abstract][Full Text] [Related]
54. Pathogenic Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid Arthritis.
Titcombe PJ; Wigerblad G; Sippl N; Zhang N; Shmagel AK; Sahlström P; Zhang Y; Barsness LO; Ghodke-Puranik Y; Baharpoor A; Hansson M; Israelsson L; Skriner K; Niewold TB; Klareskog L; Svensson CI; Amara K; Malmström V; Mueller DL
Arthritis Rheumatol; 2018 Dec; 70(12):1933-1945. PubMed ID: 29927106
[TBL] [Abstract][Full Text] [Related]
55. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis.
Lac P; Saunders S; Tutunea-Fatan E; Barra L; Bell DA; Cairns E
J Autoimmun; 2018 May; 89():75-81. PubMed ID: 29242008
[TBL] [Abstract][Full Text] [Related]
56. Citrullinated peptide and its relevance to rheumatoid arthritis: an update.
Luban S; Li ZG
Int J Rheum Dis; 2010 Oct; 13(4):284-7. PubMed ID: 21199462
[TBL] [Abstract][Full Text] [Related]
57. Production of autoantibodies against citrullinated antigens/peptides by human B cells.
Bellatin MF; Han M; Fallena M; Fan L; Xia D; Olsen N; Branch V; Karp D; Stastny P
J Immunol; 2012 Apr; 188(7):3542-50. PubMed ID: 22345652
[TBL] [Abstract][Full Text] [Related]
58. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases.
Pecani A; Alessandri C; Spinelli FR; Priori R; Riccieri V; Di Franco M; Ceccarelli F; Colasanti T; Pendolino M; Mancini R; Truglia S; Barbati C; Vomero M; Sabatinelli D; Morello F; Valesini G; Conti F
Arthritis Res Ther; 2016 Nov; 18(1):276. PubMed ID: 27887639
[TBL] [Abstract][Full Text] [Related]
59. Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage.
Brink M; Verheul MK; Rönnelid J; Berglin E; Holmdahl R; Toes RE; Klareskog L; Trouw LA; Rantapää-Dahlqvist S
Arthritis Res Ther; 2015 Feb; 17(1):25. PubMed ID: 25889922
[TBL] [Abstract][Full Text] [Related]
60. Fingerprinting of anti-citrullinated protein antibodies (ACPA): specificity, isotypes and subclasses.
Pratesi F; Panza F; Paolini I; Petrelli F; Puxeddu I; Casigliani-Rabl S; Ancillotti D; Alcaro C; Rovero P; Migliorini P
Lupus; 2015 Apr; 24(4-5):433-41. PubMed ID: 25801886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
